In other studies related to breast cancer, results that contradicted the results of this study were reported, and other tumor-related studies (liver, renal, gastric, cervical, prostate cancer, and medulloblastoma) showed that SPINT2 expression was downregulated [29,30,31,32]. This evidence concerns the gene SPINT2 and prostate carcinoma.